Trial Profile
Occurrence and characterisation of adverse events of everolimus during first and subsequent cycles in patients with metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Exemestane
- Indications Advanced breast cancer
- Focus Adverse reactions
- 01 Jun 2017 New trial record